Movidius Beefs up HW Acceleration in AI Chip
Junko Yoshida, EETimes
8/28/2017 01:31 PM EDT
MADISON, Wis. — Announcements about so-called deep learning processors are becoming almost as frequent nowadays as tweets from the White House. As the technology industry's appetite for neural networks grows, so does the demand for powerful, but very low-power inference engines adaptable to a variety of embedded systems.
Against that backdrop, Movidius, a subsidiary of Intel, launched Monday (Aug. 28) its Myriad X vision processing unit, a follow-up, after 18 months, to the Myriad 2.
Asked what separates Myriad X from other deep-learning chips announced in recent months, Remi El-Ouazzane, vice president and general manager of Movidius’ Intel New Technology Group, told us, “None of those are shipping. Myriad processors are.”
|
|
E-mail This Article |
|
Printer-Friendly Page |
|
||||||
Related News
- Axelera AI Secures up to €61.6 Million Grant to Develop Scalable AI Chiplet for High-Performance Computing
- Codasip and RED Semiconductor Sign Memorandum of Understanding to Develop AI Acceleration Technologies
- Fractile Licenses Andes Technology's RISC-V Vector Processor as It Builds Radical New Chip to Accelerate AI Inference
- BrainChip Introduces Lowest-Power AI Acceleration Co-Processor
- RaiderChip brings Meta Llama 3.2 LLM HW acceleration to low cost FPGAs
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






